Melatonin-mediated calcineurin inactivation attenuates amyloid beta-induced apoptosis
Alzheimer’s disease (AD) is the most common age-related progressive neurodegenerative disorder. The accumulation of amyloid beta-peptide is a neuropathological marker of AD. While melatonin is recognized to have protective effects on aging and neurodegenerative disorders, the therapeutic effect of m...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Elsevier
2024-06-01
|
| Sarja: | IBRO Neuroscience Reports |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2667242124000174 |